CIK 0001048477 · Large accelerated filer
BIOMARIN PHARMACEUTICAL INC
Sign in to watch- Ticker
- BMRN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 680397820
- Phone
- 4155066700
- Business address
- 105 DIGITAL DRIVE, NOVATO, CA, 94949
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,163,748
- in 1 filing
Net −$1,163,748. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-16 | Hubbard Cristin EVP, Chief Commercial Officer | Grant or award | +15,410 | 46,035 | ||
| 2026-03-16 | Hubbard Cristin EVP, Chief Commercial Officer | Grant or award · Stock Option (Right to Buy Common Stock) | +36,680 | 36,680 | ||
| 2026-03-16 | Friberg Gregory R EVP, Chief R&D Officer | Grant or award | +19,150 | 56,728 | ||
| 2026-03-16 | Friberg Gregory R EVP, Chief R&D Officer | Grant or award · Stock Option (Right to Buy Common Stock) | +45,600 | 45,600 | ||
| 2026-03-16 | Guyer Charles Greg EVP, Chief Technical Officer | Grant or award | +14,990 | 85,833 | ||
| 2026-03-16 | Guyer Charles Greg EVP, Chief Technical Officer | Grant or award · Stock Option (Right to Buy Common Stock) | +35,680 | 35,680 | ||
| 2026-03-16 | Davis George Eric EVP, Chief Legal Officer | Shares withheld for taxes | −7,177 | $58.51 | $420K | 65,263 |
| 2026-03-16 | Davis George Eric EVP, Chief Legal Officer | Grant or award | +14,570 | 79,833 | ||
| 2026-03-16 | Davis George Eric EVP, Chief Legal Officer | Grant or award · Stock Option (Right to Buy Common Stock) | +34,690 | 34,690 | ||
| 2026-03-16 | Mueller Brian EVP, Chief Financial Officer | Grant or award | +18,740 | 125,431 | ||
| 2026-03-16 | Mueller Brian EVP, Chief Financial Officer | Grant or award · Stock Option (Right to Buy Common Stock) | +44,600 | 44,600 | ||
| 2026-03-16 | Hardy Alexander Chief Executive Officer | Grant or award | +62,440 | 218,887 | ||
| 2026-03-16 | Hardy Alexander Chief Executive Officer | Grant or award · Stock Option (Right to Buy Common Stock) | +89,200 | 89,200 | ||
| 2026-03-13 | Guyer Charles Greg EVP, Chief Technical Officer | Shares withheld for taxes | −9,109 | $58.51 | $533K | 70,843 |
| 2026-03-13 | Mueller Brian EVP, Chief Financial Officer | Shares withheld for taxes | −9,945 | $58.51 | $582K | 106,691 |
| 2026-03-13 | Hardy Alexander Chief Executive Officer | Shares withheld for taxes | −2,941 | $58.51 | $172K | 156,447 |
| 2026-03-11 | Guyer Charles Greg EVP, Chief Technical Officer | Sale | −16,486 | $60.46 | $997K | 79,953 |
| 2026-02-26 | Friberg Gregory R EVP, Chief R&D Officer | Sale | −6,326 | $60.38 | $382K | 37,578 |
| 2026-02-26 | Davis George Eric EVP, Chief Legal Officer | Sale | −26,061 | $61.36 | $1.6M | 72,453 |
| 2026-02-25 | Guyer Charles Greg EVP, Chief Technical Officer | Grant or award | +6,176 | 87,393 |
Page 2 of 10 · 187 trades